Cargando…

Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation

INTRODUCTION: Estrogen receptor α-positive (ER+) breast cancers adapt to hormone deprivation and acquire resistance to antiestrogen therapies. Upon acquisition of hormone independence, ER+ breast cancer cells increase their dependence on the phosphatidylinositol-3 kinase (PI3K)/AKT pathway. We exami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fox, Emily M, Kuba, María Gabriela, Miller, Todd W, Davies, Barry R, Arteaga, Carlos L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979036/ https://www.ncbi.nlm.nih.gov/pubmed/23844554 http://dx.doi.org/10.1186/bcr3449

Ejemplares similares

The IGF-II–Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives
por: Scalia, Pierluigi, et al.
Publicado: (2020)

Integrin and autocrine IGF2 pathways control fasting insulin secretion in β-cells
por: Arous, Caroline, et al.
Publicado: (2021)

Autocrine IGF-1 Action in Adipocytes Controls Systemic IGF-1 Concentrations and Growth
por: Klöting, Nora, et al.
Publicado: (2008)

The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling
por: Martin, L-A, et al.
Publicado: (2005)

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis
por: De Giovanni, Carla, et al.
Publicado: (2019)

Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells
por: Sarfstein, Rive, et al.
Publicado: (2010)

Pancreatic Insulin Content Regulation by the Estrogen Receptor ERα
por: Alonso-Magdalena, Paloma, et al.
Publicado: (2008)

Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus
por: Kim, Min Sun, et al.
Publicado: (2015)

Werner et al. Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells
por: Sarfstein, Rive, et al.
Publicado: (2010)

Structural conservation of insulin/IGF signalling axis at the insulin receptors level in Drosophila and humans
por: Viola, Cristina M., et al.
Publicado: (2023)

Maintenance of Stemness in Oxaliplatin-Resistant Hepatocellular Carcinoma Is Associated with Increased Autocrine of IGF1
por: Bu, Yang, et al.
Publicado: (2014)

The IGF/Insulin-IGFBP Axis in Corneal Development, Wound Healing, and Disease
por: Stuard, Whitney L., et al.
Publicado: (2020)

Editorial: The Role of the IGF/Insulin-IGFBP Axis in Normal Physiology and Disease
por: Takahashi, Shin-Ichiro, et al.
Publicado: (2022)

Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights
por: Biello, Federica, et al.
Publicado: (2021)

IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR
por: Rojas, Andres, et al.
Publicado: (2011)

Differential genomic imprinting regulates paracrine and autocrine roles of IGF2 in mouse adult neurogenesis
por: Ferrón, S. R., et al.
Publicado: (2015)

Autocrine IGF2 programmes β-cell plasticity under conditions of increased metabolic demand
por: Sandovici, Ionel, et al.
Publicado: (2021)

VAPB-mediated ER-targeting stabilizes IRS-1 signalosomes to regulate insulin/IGF signaling
por: Gao, Xiu Kui, et al.
Publicado: (2023)

Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines
por: Tan, Huining, et al.
Publicado: (2009)

Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies
por: Simpson, Aaron, et al.
Publicado: (2017)

The Roles of the IGF Axis in the Regulation of the Metabolism: Interaction and Difference between Insulin Receptor Signaling and IGF-I Receptor Signaling
por: Okuyama, Tomoko, et al.
Publicado: (2021)

Obesity, Diabetes, and Cancer: The Role of the Insulin/IGF Axis; Mechanisms and Clinical Implications
por: Morrione, Andrea, et al.
Publicado: (2022)

Glucagon-Like Peptide-1 Protects β-Cells Against Apoptosis by Increasing the Activity of an Igf-2/Igf-1 Receptor Autocrine Loop
por: Cornu, Marion, et al.
Publicado: (2009)

Abrogating endocrine resistance by targeting ERα and PI3K in breast cancer
por: Fox, Emily M., et al.
Publicado: (2012)

Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cells
por: Weinstein, Doron, et al.
Publicado: (2014)

High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer
por: Traphagen, Nicole A., et al.
Publicado: (2021)

R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis
por: Huang, Helen J., et al.
Publicado: (2011)

Interaction between IGF-IR and ER Induced by E2 and IGF-I
por: Yu, Zhenghong, et al.
Publicado: (2013)

Gestational Diabetes Mellitus and Energy-Dense Diet: What Is the Role of the Insulin/IGF Axis?
por: Martín-Estal, Irene, et al.
Publicado: (2022)

Update on new GH-IGF axis genetic defects
por: Vasques, Gabriela A., et al.
Publicado: (2019)

Therapeutic Targeting of the IGF Axis
por: Osher, Eliot, et al.
Publicado: (2019)

Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females
por: Savastano, Silvia, et al.
Publicado: (2011)

Autocrine production of reproductive axis neuropeptides affects proliferation of canine osteosarcoma in vitro
por: Weinman, Marcus A., et al.
Publicado: (2019)

Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancer
por: Yang, Wei, et al.
Publicado: (2018)

Prevention of Obesity and Insulin Resistance by Estrogens Requires ERα Activation Function-2 (ERαAF-2), Whereas ERαAF-1 Is Dispensable
por: Handgraaf, Sandra, et al.
Publicado: (2013)

Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling
por: Pham, Thu Ha, et al.
Publicado: (2021)

Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation
por: Cioce, M, et al.
Publicado: (2014)

BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma
por: Loganathan, Sudan N., et al.
Publicado: (2016)

DPP-4 Inhibitor and Estrogen Share Similar Efficacy Against Cardiac Ischemic-Reperfusion Injury in Obese-Insulin Resistant and Estrogen-Deprived Female Rats
por: Sivasinprasasn, Sivaporn, et al.
Publicado: (2017)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_i5fj4h0dlmr5v862omfga2678p